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ABSTRACT 
With the rapid pace of development in the pharmaceutical industries the researchers are equally contributing in developing the latest 
technology for their growth. The computer aided design and manufacturing that provides 3 dimensional (3D) printed dosage forms which the 
new step is being that to be taken into a consideration. With the Food and Drug Administration (FDA) approval to first 3D pri nted tablet in 
August 2015, Spritam®, since the 3D printing has become a novel method for the design of drug delivery system. It has the capability of 
dispensing the drug more accurately, precisely and layer by layer assembly which helps in forming complex composition and geometries. It 
enables the preparation of personalised dosage form and tailored release profiles. Therefore, it can be seen as a future of solid dosage forms 
produced on demand, with customised dose and in lower cost. It can also help in reducing side effects caused by excessive doses. This review 
highlights the 3D printing technology and its applications in growth of pharmaceutical sector. The novel technology is simple, rapid and design 
most complex things. Hence this technology can take drug delivery technology to another horizon.  
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INTRODUCTION 
The 3D printing is progressively growing in all the corners of 
the world. With its enormous potential for applications in 
infinite areas, the 3D printing technology has become a topic 
of interest of technology enthusiasts, manufacturers and 
media with a sense of curiosity. In the last few decades, the 
3D printing industry has shown aemission of low cost 
printers entering the market due to the expiration of certain 
technological patents which helped in popularizing 3D 
printing further. Globally, 3D printing is already a $6 billion 
market and is expected to cross $8.43 billion by 2020, which 
not too far ahead. It may be a good time for India to seriously 
think of a ‘Print in India’ campaign. 1 
Three dimensional printing (3DP) is particularly an 
emerging technology expected to develop pharmaceutical 
manufacturing along with other fields. The 3DP technologies 
have capability to produce limitless dosage forms that are 
challenges conventional drug fabrication methods not only 
in product quality and efficacy but also in cost efficiency 
because of 3D printers have already been successful in 
producing novel dosage forms within minutes. Three 
situations where this on-demand pharmacy capability may 
be applicable include printing directly on the implants or 
tissue scaffolds, printing “just in-time” in healthcare facilities 
or in other resource-constrained settings and printing low-
stability drugs for immediate consumption. In all these 
circumstances this technology provides attractive solution to 
explore on demand pharmacy. 2 
Three dimensional printing is a comparatively new rapid 
prototyping (RP) technique. The system was first developed 
at the Massachusetts Institute of Technology (1992) and is 
based on computer aided design (CAD) models that are 
manipulated by a terminal computer. The 3DP system 
involved a very simple layer wise process that can be 
applied rapidly.3 The 3D object is made by deposition of 
material or by binding of materials in successive layers. 4. 
Three dimensional objects are rapidly made on a reasonably 
sized machine connected to computer containing blueprints 
for the object. 5 
The 3DP or additive manufacturing (AM) is a process of 
making three dimensional solid objects from a digital file [5]. 
It is a powerful unique technology, first described by Charles 
Hull as “stereo lithography” in 1986. It uses “STL” file 
format” to interpret the data in CAD file. These data 
instructions are electronically communicated to the 3D 
printer. These instructions include the texture, shape, size 
and thickness of the object to be printed. The 3DP is a layer-
by-layer process having capability to produce 3D drug 
products from digital file. The 3DP technology is 
unparalleled, flexible, rapid and with exceptional 
manufacturing capability of pharmaceutical drug products of 
desired quality. 6 
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The first 3D printed drug to receive approval from the 
United State FDA is now being shipped to pharmacies. The 
Pennsylvania based Aprecia Pharmaceuticals said its 3D-
printed Spritam® (levetiracetam) tablets are used to treat 
epilepsy. The company is also working on at least three 
other 3D printed drugs that it expects to eventually bring to 
market. 7 
HISTORY  
The Charles (Chuck) developed the first 3D printer in 1984 
and named the technique as Stereo Lithography. In 1993 
MIT used 2D ink jet printing technology to 3D printers 
named it as 3 dimensional printing techniques. The Z 
Corporation obtained licences from MIT in 1995 and started 
to develop 3D printers for general market. Z Corporation 
launched first high definition colour 3D printer in 2005. It 
follows the achievement of RERAP the first open source 3D 
printer introduced by Cornell University in 2006. The first 
3D printer that could produce functional prototype parts 
was introduced, which made a great achievement Urbee, the 
first car ever with three wheels and two seats to have its 
entire body printed out on a giant 3D printer. Recently in 
August 2014, Organovo the pioneer in biological 3D printing 
company demonstrated that its 3D human liver system can 
detect the toxicity of a drug. 8 
ADVANTAGES 
3-D Printing technology has the following advantages:  
1. Lower cost: In China they were able to construct 10 
one storey houses at less than $5000 per house. 
Construction of a similar house costs is more than the 
stipulated price.  
2. Time: Three dimensional printing allows constructing 
working models in just hours instead of days or weeks. 
3. Efficiency: Generating prototypes with 3D printers is 
much easier and faster.  
4. Flexible: Different materials can be used in the 3 D 
models. It makes very easy to create construction 
models or prototypes for a wide variety of projects 
within many industries. 
5. Durable products: The objects do not absorb 
moisture or warp over time making them last for 
longer.  
6. Quality: The products with an excellent surface finish 
are produced.  
7. Functional models: Realistic live functional models 
can be produced as opposed to working with paper of 
digital models. 9 
DISADVANTAGES 
1. Intellectual property problem: The comfort with which 
replicas can be created using 3D technology raises issues 
over intellectual property rights. The availability of 
blueprints online free of cost may change with for-profit 
organizations wanting to generate profits from this new 
technology.  
2. Limitations of size: The 3D printing technology is 
currently limited by size limitations. Very large objects are 
still not possible when built using 3D printers.  
3. Limitations of raw material: At present, 3D printers can 
work with approximately 100 different raw materials. This 
is insignificant when compared with the enormous range of 
raw materials used in traditional manufacturing. More 
research is required to devise methods to enable 3D printed 
products to be more durable and robust.  
4. Cost of printers: The cost of buying a 3D printer still does 
not make its purchase by the average householder possible. 
Also, different 3D printers are required in order to print 
different types of objects. Also, printers that can 
manufacture in colour are costlier than those that print 
monochrome objects. 
5. Fewer manufacturing jobs: As with all new technologies, 
manufacturing jobs will decrease. This disadvantage can 
have a large impact to the economies of third world 
countries especially China, that depend on a large number of 
low skill jobs.  
6. Unchecked production of danger items: Liberator, the 
world’s first 3D printed functional gun, showed how easy it 
was to produce one’s own weapons, provided one had access 
to the design and a 3D printer. Governments will need to 
devise ways and means to check this dangerous tendency. 10 
PRINCIPLE  
The main principle of 3DP is stereo lithography, outlined by 
Charles Hull in a 1984 patent as “a system for generating 
three-dimensional objects by making a cross-sectional 
pattern of the object to be formed”. This means that any 3D 
object generated using a 3D drawing software is firstly split 
into layers and then these layers are then successively 
printed by the machine on top of one another.11 
The main 3 steps involved during 3DP process which are 
described as follows: 
1. Modelling: The 3D printable models may be created with 
a CAD package, via a 3D scanner or by a plain digital camera 
and photogrammetric software. The modelling process of 
preparing geometric data for 3D computer graphics is 
similar to plastic arts such as sculpting. The 3D scanning is a 
process of collecting digital data on the shape and 
appearance of a real object, creating a digital model based on 
it.  
2. Printing: The 3D model from the STL file must first be 
examined for "manifold errors," before printing, this step 
termed as the "fix up." Generally from a model obtained 
through 3D scanning, STL file have been produced and have 
many manifold errors in them that need to be rectified. 
Examples of these errors are surfaces that do not connect, or 
gaps in the models. STL file need to be processed by a piece 
of software called a "slicer," which converts the model into a 
series of thin layers and produces a G-code file containing 
instructions tailored to a specific type of 3D printer (FDM 
printers). Then with 3DP client software G-code file can be 
printed (which loads the G code, and uses it to instruct the 
3D printer during the 3DP process)? Layer thickness and X–
Y resolution in dots per inch (dpi) or micrometers (µm) 
describe by the printer resolution. The typical layer 
thickness is around 100 µm (250 dpi), even though some 
machines can print layers as thin as 16 µm (1,600 dpi). X-Y 
resolution is comparable to that of laser printers. The 
particles (3D dots) are around 50 to 100 µm (510 to 250 
dpi) in diameter.  
Depending upon the method used the size and complexity of 
the model and construction of a model with contemporary 
methods can take anywhere from several hours to several 
days Additive manufacturing systems can reduce this time to 
a few hours, although it varies widely depending on the type 
of machine used and the size and number of models being 
produced simultaneously. Traditional techniques like 
injection molding can be less expensive for manufacturing 
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polymer products in high quantities, but additive 
manufacturing can be faster, more flexible and less 
expensive when producing relatively small quantities of 
parts. The 3D printers give designers and concept 
development teams the ability to produce parts and concept 
models using a desktop size printer.  
3. Finishing: However the printer produced resolution is 
sufficient for lots of applications, printing a slightly 
oversized version of the desired object in standard 
resolution, and then removing material with a higher 
resolution subtractive process can achieve greater precision. 
Some printable polymers allow the surface finish to be 
smoothed and improved by using chemical vapor processes. 
Some additive manufacturing techniques are capable of 
using multiple materials in the course of constructing parts.  
These techniques are able to print in multiple colors and 
color combinations simultaneously, and would not 
necessarily require painting. Some printing techniques 
require internal supports to be built for overhanging 
features during construction. These supports must be 
mechanically removed or dissolved upon completion of the 
print. All of the commercialized metal 3D printers involve 
cutting the metal component off of the metal substrate after 
deposition. A new process for the GMAW 3DP allows for 
substrate surface modifications to remove aluminum or steel 
12 
TYPES OF 3D PRINTING  
1) Fused Deposition Modelling (FDM): Fused Deposition 
Modelling is an additive manufacturing technology generally 
used for modelling, prototyping and production applications. 
It works on an "additive" principle by laying down the 
successive layers of materials in series. A plastic filament or 
metal wire is unwound from a coil and supplies material to 
an extrusion nozzle which can turn the flow on and off. To 
melt the material the nozzle is heated and can be moved in 
both horizontal and vertical directions by a numerically 
controlled mechanism, directly controlled by a computer-
aided manufacturing (CAM) software package. The model  is 
produced by extruding small beads of thermoplastic 
material to form layers as the material hardens immediately 
after extrusion from the nozzle. Stepper motors or servo 
motors are typically employed to move the extrusion head. 
FDM, a prominent form of rapid prototyping, is used for 
prototyping and rapid manufacturing.  
Advantages: Cheaper since expensive models use a different 
(water soluble) material to remove supports completely.  
Even cheap 3D printers have enough resolution for many 
applications.    
Disadvantages: Supports leave marks that require 
removing and sanding. Because of Thermo plastic material 
warping limited texting is allowed. 5 
 
 
2) Stereo Lithography: Charles Hull discovered this 
technique in 1988 as a first printing technique of 3D system. 
During the printing process photopolymer material like resin 
or acrylate was used which can cured by UV laser. 11 
It is rapid and popular prototyping technology which can 
produce highly accurate and detailed polymer parts. Stereo 
lithography builds objects one layer at a time by tracing a 
laser beam on the surface of a vat of liquid photopolymer, 
inside of which is a movable stage to support the part being 
built. Wherever the laser beam strikes the surface of the 
liquid the photopolymer quickly solidifies. The platform is 
lowered by a distance equal to the layer thickness (typically 
0.003-0.002 inch), and a resultant layer is formed on top of 
the previously completed layers. Thus three dimensional 
object out of many layers formed completely due to the self-
adhesive property of material causes each succeeding layer 
to bond to the earlier one. Objects which have overhangs or 
undercuts must be supported during the fabrication process 
by support structures. These are either manually or 
automatically designed with a computer program developed 
for rapid prototyping. Once complete, the part is elevated 
above the vat and drained. Excess polymer is swabbed or 
rinsed away from the surfaces. In several cases, a final cure is 
given by placing the part in a UV oven. After the final cure, 
supports are cut off the part and surfaces are polished, 
sanded or otherwise finished. 13  
Advantages: For prototyping this technique is most 
commomly used as it is less time-consuming and it is 
Nozzle 
Object 
Support material 
Platform 
Heater elements 
Material pool 
Fig.1. Fused deposition modelling. 
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relatively cheaper compared to other prototyping method.  
Nevertheless, the SLA process requires support structures 
for some parts mainly for those with overhangs. 
SLA is one of the most accurate 3DP processes with excellent 
surface finish and smoother surface than most other rapid 
prototyping methods. Smooth surface indicates a great level 
of detail and the design is very accurate. Moreover parts can 
be printed in a very short period of time depending on its 
size and shape. SLA also allows different options when it 
comes to material. Although SLA can produce a large variety 
of shapes, it is often very expensive 14 
Disadvantages: This method is extremely high resolution 
and considerably fast, but the nature of the pool of drug-
loaded material has an inherent risk of cross contamination 
between the fabrications of different drug products. 15 
 
 
3) Laminated object manufacturing (LOM): It is a 3D 
printing technology developed by Helisys Inc. (now Cubic 
Technologies). In LOM technology layers of adhesive-coated 
paper, plastic, or metal laminates are successively joined 
together and cut to appropriate shape with a laser cutter. 
After the printing process, the objects may be additionally 
modified by machining. The typical layer resolution for this 
process is defined by material feedstock and usually ranges 
in thickness from one to a many sheets of paper of a copy. 10 
As the name indicates the process laminates thin sheets of 
film. The laser has only to cut the periphery of each layer. In 
this process to take-up roller on the other side the build 
material is stretched from a supply roller across a platform. 
A heated roller passes over the paper bonding it to the 
platform. A laser, focused to penetrate through one thickness 
of paper cuts the profile of that layer. The excess around and 
inside the model is carved into small squares to facilitate its 
removal. The objects created using LOM technique are 
durable, multilayered structures which can be machined, 
sanded, polished, coated and painted. It is used as visual 
models and for limiting testing 8. 
 
 
4) Selective Laser Sintering (SLS): Selective laser sintering 
is a quick manufacturing process based on the use of powder 
coated metal additives, a process generally used for rapid 
prototyping.  For scanning and aligning particles in 
predetermined sizes and shapes of the layers a continuous 
laser beam are used as heating source. The geometry of the 
scanned layers corresponds to various sections of the 
models established by computer-aided design (CAD) or from 
files produced by stereo-lithography. After scanning the first 
layer, the scanning of second layer continues which is placed 
over the first, repeating the process from the bottom to the 
top until the product is complete. 16 
To fuse small particles of plastic, metal, ceramic or glass 
powders into a mass that has the desired three dimensional 
shape, this technology uses high power laser. The laser 
Platform 
Mirror Laser 
Sheet material 
Layer counter 
Take up roll 
Optic block 
Tile 
Fig. 3. Laminated object manufacturing principle. 
 
Movable optic head 
Elevator 
Scatter mirror 
Laser source 
Cured layers 
UV curable resin  
Movable platform 
Resin tank 
Fig. 2. Stereo Lithography principle. 
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selectively fuses the powdered material by scanning the 
cross-sections (or layers) generated by the 3D modelling 
program on the surface of a powder bed. After each cross 
section is scanned, the powder bed is lowered by one layer 
thickness. Then a new layer of material is applied on top and 
the process is repeated until the object is completed. All 
untouched powder remains as it is and becomes a support 
structure for the object. Therefore there is no need for any 
support structure which is an advantage over SLS and SLA. 
All unused powder can be used for the next print. SLS was 
developed and patented by Dr. Carl Deckard at the 
University of Texas in the mid-1980s 17 
 
 
3DP IN PHARMACEUTICALS 
To making nice medicine 3DP promises a future of drugs 
printed on demand, to custom doses, and the possibility that 
cost may no longer be a barrier. And children could be 
among the patients to benefit most. 
The potential of 3DP is about being able to deliver what one 
want when one want, says engineer Ricky Wildman from 
University of Nottingham in the United Kingdom. They were 
trying to find the right materials that can be used as inks to 
make tablets with varying doses of drugs. In particular, 
Wildman is looking at inkjet 3D printing. He has replaced 
coloured inks with polymers, drugs and other materials used 
in pill manufacture. Using inkjet he is exploring the 
techniques by which suspensions and liquid-based materials 
can be triggered to make solids. 18 
Mohamed Albed Alhnan, a pharmaceutical scientist at the 
University of Central Lancashire in Preston UK, says that the 
trouble with this technology is finding the right materials. He 
used fused deposition modelling (FDM) based 3D printer to 
fabricate extended release tablet of prednisolone loaded 
polyvinyl alcohol (PVA) filaments and to control its dose. 19 
Goyanes A., have explored the feasibility of fabricating 
controlled release budesonide tablet using fused deposition 
modelling (FDM), 3DPtechnology with hot melt extrusion 
(HME) and fluidized bed coating. Budesonide was loaded in 
polyvinyl alcohol filaments using HME. Capsule shaped 
tablets containing budesonide were prepared by 
engineering the filaments using a FDM 3D printer and were 
further over coated with layer of enteric polymer. The 
formulation was tested in dynamic dissolution bicarbonate 
buffer system with commercial budesonide products. The 
new 3D printed caplet formulation showed sustained release 
throughout the distal intestine and colon.  
 
 
He has also prepared drug-loaded paracetamol and caffeine 
filaments of polyvinyl alcohol with fused-deposition 
modelling of 3DP. The design configurations included a 
multilayer device, with each layer containing drug, whose 
identity was different to the drug in the adjacent layers, and 
a two-compartment device comprising a caplet embedded 
within a larger caplet (DuoCaplet), with each compartment 
containing a different drug. 
  
(A)    (B)   (C) 
Fig.5. Caplet prior to coating (A), caplet after coating (B) and cross section of coated caplet (C) 
20 
Laser 
Scanning mirror 
Roller 
Building platform 
Piston 
Powder 
Fig. 4. Selective laser sintering principle. 
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Wang J. evaluated the suitability of stereo lithography (SLA) 
to fabricate drug-loaded tablets with modified-release 
characteristics. The SLA printer made solid objects by using a 
laser beam to photo polymerise monomers. They used 
polyethylene glycol diacrylate (PEGDA) as a monomer and 
diphenyl (2, 4, 6-trimethylbenzoyl) phosphine oxide was 
used as a photo-initiator. Acetaminophen (paracetamol) and 
4-aminosalicylic acid (4-ASA) were selected as model drug. 
By adding polyethylene glycol 300 (PEG 300) to the printing 
solution tablets and formulation were printed and fabricated 
with different properties. The loading of 4-ASA and 
paracetamol in the printed tablets was 5.40% and 5.69% 
respectively. In a realistic dynamic dissolution simulation of 
the gastrointestinal tract, drug release from the tablets was 
dependent on the composition of the formulations, but 
independent of dissolution pH. In conclusion, the SLA 3DP 
technology allows the manufacture of drug loaded tablets 
with specific extended-release profiles. In the future this 
technology could become a manufacturing technology for the 
elaboration of oral dosage forms, for industrial production or 
also for personalised dose. 22 
Aprecia Pharmaceuticals based in Langhorne, Pennsylvania, 
filed its first 3D-printed product for approval to the US Food 
and Drug Administration (FDA) in Oct 2014. The company is 
developing a system that can print large doses of drugs in a 
formulation that makes them easy to swallow. Aprecia’s 
product, called ZipDose, is built up from layer upon layer of 
powders of the drug bound together by droplets of liquid.  23 
3DP in fabrication of novel drug delivery system (NDDS) 
Drug delivery means delivery of an active pharmaceutical 
ingredient (API) in the body or at the specific site to achieve 
its desired therapeutic effect. The idea of drug delivery has 
greatly progressed over the years from conventional dosage 
forms to novel target drug delivery systems. Therefore, the 
conventional method like direct tableting are now 
progressively evolved towards multi-step manufacturing 
technologies, including granulation, extrusion or coating 
processes, to allow the development of controlled-release 
systems. Recently the novel concepts of formulation have 
emerged (For e.g., nano-scale medicines, biomimetic 
particles and functionalized liposomes) as well as more 
sophisticated manufacturing methods. Thus, 3DP process 
naturally appeared to be an essential tool in research and 
development area to fit with actual industrial directions of 
reducing both time and costs in the early stage of a novel 
manufacturing concept, reducing the inherent risk of new 
development to fail at later stages. 3DP in pharmaceutical 
industry represents a well-designed tool for designing 
simple, accurate, cheap, structured and tailored drug 
delivery systems. This flexibility can offer many novel 
strategic approaches for the research and development of 
controlled-release drug delivery systems. In the last 15 
years, a large variety of 3DP have been introduced into the 
rapid prototyping industry. 24 The few of the applications of 
3DP were enlisted in Table 1. 
 
Table 1: Drug delivery systems fabricated using 3DP 
Researcher Dosage form Special remark 
Katstra et al. Oral dosage forms Excellent content uniformity and dosage control than conventional mixing 
and pressing techniques. 25 
Shaban et al. Guaifenesin bi-layer tablets Satisfied the need of regulatory standards which matches with the release of 
standard commercial tablets. 26 
Khaled et al. Multi-active solid dosage form The polypill contain an immediate release compartment for aspirin and 
hydrochlorothiazide and three sustained release compartments containing 
pravastatin, atenolol and ramipril. 27 
Byung et al. Paclitaxel-loaded poly (lactic-
co-glycolic acid) polymer 
microparticles 
The microparticles showed a biphasic release profile with an initial burst 
due to diffusion and subsequent sustained release due to degradation of 
polymer. The microparticles with well-defined and controlled shapes. [28] 
Parawee et al. Encapsulate dexamethasone 
salt within PLGA and PVA 
To control the drug release profile by using novel extrusion printing 
technology and the in vitro studies showed minor burst release with 
sustained release up to 4 months. 29 
Rowe et al. Pulsatile drug delivery of 
chlorpheniramine maleate 
(CPM). 
Pulsed release of CPM after a lag time of 10 min, followed by extended 
release up to 7 hr. Breakaway erodible tablets composed of three sections, 
an interior fast-eroding section separated by two drug-releasing sub-units 
which erode in 30-45 min in simulated gastric fluid. 30 
Wang et al. Zero-order controlled-release 
pseudoephedrine.HCL 
formulations 
The mixtures of Kollidon SR and hydroxypropyl methylcellulose were used 
as drug carriers to develop a formulation using 3DP technology. 31 
Fig.6. Caplet embedded within a larger caplet (DuoCaplet), with each compartment 
containing a different drug.21 
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Melocchi et al. Oral pulsatile release capsular 
device 
Using fused deposition modelling 3D printer, fabricated the capsular device 
for oral pulsatile release using erodible hydroxypropyl cellulose (HPC). 32 
Deng et al Novel doughnut-shaped multi-
layered acetaminophen delivery 
devices 
Based on computer-aided design models, different devices containing 
acetaminophen, hydroxypropyl methylcellulose as matrix and ethyl 
cellulose (EC) as a release-retardant material were prepared automatically 
using a three-dimensional printing system. 33 
Deng et al. Novel fast disintegrating tablet Which have special inner structure characteristics using 3D printer. 34 
Nikolaos et al. Felodipine solid dispersion Felodipine solid dispersion using polyvinyl pyrrolidone by inkjet printer. 35 
Alvaro et al. Salicylic acid patches To treat acne using stereo lithography printer. The patch showed high drug 
loading with release rate of 291 μg/cm2 for 3 hr. 36 
Muzna et al. Immediate release tablets Non-melting filler which allowed a consistent flow from printer’s nozzle to 
facilitate 3D printed tablets using Eudragit as a polymer filament with four 
different physiological drugs entrapped. Tablets possessed excellent 
mechanical strength and acceptable in-batch variations. 37 
Netalia et al. Controlled-release oral dosage 
forms 
Accurate dosing and tailored drug delivery according to dosage 
requirements. 38 
Gyeong et al. Novel 3D-printed patches Composed of a blend of poly (lactide-co-glycolide), polycaprolactone, and 5-
fluorouracil to deliver the anti-cancer drug in a sustained manner for 4 
weeks when applied at tumor site. 39 
Netalia et al. T-shaped intrauterine systems 
and subcutaneous rods to 
deliver drugs up to 30 days. 
Investigated the printability of different grades of ethylene vinyl acetate 
copolymers for fused-deposition modelling based 3DP technology. 40 
Deng et al. Novel fast disintegrating tablet 
using computer-aided models 
(3D printer) 
To have control over the material composition, microstructure, and surface 
texture. 41 
Deng et al. Zero-order drug release tablets 
using 3D printer. 
The matrix tablets with 68% drug weight exhibited material gradients in 
radial direction with drug-free release-barrier layers on both the sides. In 
vitro results showed linear release up to 12 hr, through two-dimensional 
surface erosion mechanism. 42 
Alvaro et al. Capsule-shaped solid devices 
loaded with multiple drugs. 
Used multi-nozzle 3D printer for the fabrication. Device was loaded with 
acetaminophen and caffeine. 43 
 
CONCLUSION  
3D printing is a layer- by-layer, automated process capable of 
producing complex, personalised products on demand. In 
recent years, researchers proposed dozen of 3d printing 
innovations to improve the safety, efficacy,and tolerability of 
medicines. The commercial feasibility of this technology  has 
been shown through the FDA approval of 3D printed drug 
product in august 2015  
With so much interest and research found in the past few 
years, 3D printing in pharmaceutics has reached an 
impressive rhythm of development and promises great 
progress in the future. 3DP is a simple, cost-effective way of 
manufacturing personalised oral medicines and other drug 
devices.  
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